In our study, observed cross-cohort increase in the levels of C-reactive protein was especially striking when contrasted to the lack of difference in levels of CRP when patients with any cardiovascular disease were compared to the cohort with any non-cardiovascular morbidity. The gene discussed is CRP; the disease is cardiovascular disorder.